CohBar. has filed a patent related to peptides that modulate cellular mechanisms controlling cell viability, proliferation, and metabolic processes. The peptide, as per Claim 1, comprises a specific amino acid sequence. This innovation has potential applications in treating metabolic diseases and as cytoprotective agents. GlobalData’s report on CohBar gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights CohBar Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on CohBar, Peptide pharmacophores was a key innovation area identified from patents. CohBar's grant share as of January 2024 was 8%. Grant share is based on the ratio of number of grants to total number of patents.

A recently filed patent (Publication Number: US20240034753A1) discloses a series of peptides with specific amino acid sequences and compositions for potential pharmaceutical applications. The peptides described in the patent have distinct amino acid sequences, with variations in the selection of amino acids at different positions within the sequence. These peptides are designed to have specific biological activities, including modulating cell viability, treating cancer, cell proliferation, apoptotic diseases, metabolic diseases such as obesity and diabetes, and providing cytoprotection. The patent also covers compositions comprising these peptides and their use in manufacturing medicaments for treating metabolic diseases.

Furthermore, the patent includes claims related to the length of the peptides, their effects on fatty acid metabolism, and the use of non-naturally occurring amino acid residues in the peptide sequences. The disclosed peptides are intended to have pharmacological effects on various cellular processes, making them potentially valuable in the development of novel therapeutic interventions. The patent also outlines methods for administering the peptides to patients in need of treatment for metabolic diseases, highlighting the potential clinical applications of these peptide-based compositions in the healthcare industry.

To know more about GlobalData’s detailed insights on CohBar, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies